Invesaro

Stocks Comparison

agilon health vs Charming Medical: revenue, profit, margins and growth compared

agilon health brought in $5.9B of revenue in fiscal 2025, Charming Medical $4.8M in fiscal 2026. Revenue changed by -2.1% at agilon health and -22.7% at Charming Medical on the year before, so agilon health grew faster. agilon health kept -6.6% of its revenue as net profit, Charming Medical -0.5%. Free cash flow was -$119M at agilon health and -$1.6M at Charming Medical.

Side by side, latest fiscal year

AGLMCTA
Fiscal year endedFY2025 (December 31, 2025)FY2026 (March 31, 2026)
Revenue$5.9B$4.8M
Revenue growth-2.1%-22.7%
Net income-$391.3M-$22.6K
Net margin-6.6%-0.5%
Free cash flow-$119M-$1.6M
Free cash flow margin-2.0%-32.4%
Earnings per share (diluted)n/a$0.00
Cash$173.7M$4.7M
Debt$35M$185.8K
Price to earningsn/an/a
Market value$1.4Bn/a
Dividend yieldn/an/a
Rank by revenue in sector#58 of 646 · Health care#509 of 646 · Health care

Over the years

Revenue
AGL FY2019: $794.4MAGL FY2021: $1.2BAGL FY2021: $1.5BAGL FY2022: $2.4BAGL FY2023: $4.3BAGL FY2024: $6.1BAGL FY2025: $5.9BMCTA FY2024: $6MMCTA FY2026: $6.2MMCTA FY2026: $4.8MFY19FY21FY22FY23FY24FY25FY26
AGL $5.9BMCTA $4.8M
Net income
AGL FY2019: -$282.6MAGL FY2021: -$60.1MAGL FY2021: -$406.5MAGL FY2022: -$106.6MAGL FY2023: -$262.6MAGL FY2024: -$260.2MAGL FY2025: -$391.3MMCTA FY2024: $777.8KMCTA FY2026: $1.2MMCTA FY2026: -$22.6KFY19FY21FY22FY23FY24FY25FY26
AGL -$391.3MMCTA -$22.6K
Net margin
AGL FY2019: -35.6%AGL FY2021: -4.9%AGL FY2021: -26.7%AGL FY2022: -4.5%AGL FY2023: -6.1%AGL FY2024: -4.3%AGL FY2025: -6.6%MCTA FY2024: 12.9%MCTA FY2026: 19.3%MCTA FY2026: -0.5%FY19FY21FY22FY23FY24FY25FY26
AGL -6.6%MCTA -0.5%
Revenue growth
AGL FY2021: +53.4%AGL FY2021: +24.9%AGL FY2022: +57.0%AGL FY2023: +80.7%AGL FY2024: +40.4%AGL FY2025: -2.1%MCTA FY2026: +3.4%MCTA FY2026: -22.7%FY21FY22FY23FY24FY25FY26
AGL -2.1%MCTA -22.7%
Free cash flow
AGL FY2019: -$106.8MAGL FY2021: -$55MAGL FY2021: -$154.7MAGL FY2022: -$146.2MAGL FY2023: -$172MAGL FY2024: -$71MAGL FY2025: -$119MMCTA FY2024: $84.8KMCTA FY2026: $138.4KMCTA FY2026: -$1.6MFY19FY21FY22FY23FY24FY25FY26
AGL -$119MMCTA -$1.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about agilon health and Charming Medical

Which is bigger by revenue, agilon health or Charming Medical?

agilon health is bigger by revenue: $5.9B in fiscal 2025, against $4.8M for Charming Medical in fiscal 2026.

Which keeps more of its revenue as profit, agilon health or Charming Medical?

agilon health had a net margin of -6.6% in fiscal 2025; Charming Medical had -0.5% in fiscal 2026.

Which grew revenue faster, agilon health or Charming Medical?

In their latest fiscal years revenue changed by -2.1% at agilon health and -22.7% at Charming Medical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies